6 rezultatus
Design: an international, multicenter, double-blind, placebo-controlled, randomized study in parallel groups.
The study will enroll children of either gender aged of 1 month to 6 years old. Children can participate in the study, regardless of the frequency of previous ARVI. A potential study
- Study Design: Prospective double blinded randomized placebo-controlled Clinical trial
- Time plan: Approximately 6 months according to calculated sample size.
- study setting: this study will be conducted obstetrics and gynecology department at Cairo university.
- study population: patient will be
A prospective, randomised, double-blind, controlled clinical trial (RCT) was conducted to compare the efficacy and clinical safety of the induction of labour using the combination of isosorbide dinitrate-oxytocin (experimental arm, X = 1) compared to misoprostol-oxytocin (standard arm, X = 0). The
This study consisted of a first screening visit with a Neurologist of the Headache Science Centre of the IRCCS Mondino Foundation, during which a full neurological and general examination was performed, and the data collected on the routine headache diary used by all patients attending Mondino
Hepatocyte growth factor (HGF) is local acute phase protein with regenerative properties that become biologic inactive during chronic inflammation and loses the binding affinity to glycosaminoglycan in the extracellular ma-trix. HGF is excreted into the gastrointestinal tract and is not detected in
Methods:
200 infants (<2 years old) will be enrolled into the study. Clinical data will be gathered from the emergency room file, and in case of admission from the discharge letter and the clinical file. Based on the current protocols of treatment and diagnosis of children with head injury, CT will